Although the effect of OCN on the IgE-activated mast cells has not been identified, effective mast cell inhibitor medications used in preformed obesity and diabetes in experimental models offer hope to patients with these common chronic inflammatory diseases [37]. This evidence concerns the gene IGHE and diabetes mellitus.